Why Basel Medical Group (NASDAQ: BMGL) Is in Focus Following Reverse Stock Split Approval

Basel Medical Group (NASDAQ: BMGL) announced that it will implement a 1-for-12 reverse stock split effective June 22, 2026.

Nitish Kishor | 10 June 2026

Why CervoMed (NASDAQ: CRVO) Is in Focus Following Private Placement Financing

CervoMed (NASDAQ: CRVO) announced a private placement expected to generate approximately $10.5 million in upfront gross proceeds.

Nitish Kishor | 10 June 2026

Why Rafael Holdings (NYSE: RFL) Is in Focus Following Key Phase 3 Trial Milestone

Rafael Holdings (NYSE: RFL) announced the successful completion of the Last Patient Last Visit milestone for the final 96-week treatment period in its global Phase 3 TransportNPC clinical trial.

Nitish Kishor | 10 June 2026

Why Polyrizon (NASDAQ: PLRZ) Is in Focus After European Patent Publication

Polyrizon (NASDAQ: PLRZ) announced that the European Patent Office published its patent application covering the company's Trap & Target mucoadhesive nasal-delivery technology.

Nitish Kishor | 10 June 2026

Why Dianthus Therapeutics (NASDAQ: DNTH) Is in Focus After Sanofi Ends Phase 3 Riliprubart Trial

Dianthus Therapeutics (NASDAQ: DNTH) is in focus following a major development in the neuro-immunology sector. Sanofi (NASDAQ: SNY) announced the termination of its Phase 3 MOBILIZE trial evaluating riliprubart after the study failed to demonstrate sufficient clinical efficacy.

Nitish Kishor | 10 June 2026

Why DLocal (NASDAQ: DLO) Stock Is Up 8% Today

Why DLocal (NASDAQ: DLO) Stock Is Climbing

Nitish Kishor | 10 June 2026

Why Robinhood Markets (NASDAQ: HOOD) Stock Is Up 8% Today

Robinhood Markets (NASDAQ: HOOD) shares are climbing sharply as investors respond to a powerful combination of strong operating performance, strategic business expansion, bullish Wall Street commentary, and a notable insider purchase.

Nitish Kishor | 10 June 2026